LODOSYN Drug Patent Profile

✉ Email this page to a colleague

When do Lodosyn patents expire, and what generic alternatives are available?

Lodosyn is a drug marketed by Aton and is included in one NDA.

The generic ingredient in LODOSYN is carbidopa. There are eighteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the carbidopa profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Lodosyn

A generic version of LODOSYN was approved as carbidopa by ALVOGEN on January 8^th, 2016.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for LODOSYN?
What are the global sales for LODOSYN?
What is Average Wholesale Price for LODOSYN?

Summary for LODOSYN

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	2
Raw Ingredient (Bulk) Api Vendors:	78
Clinical Trials:	10
Patent Applications:	5,320
Drug Prices:	Drug price information for LODOSYN
What excipients (inactive ingredients) are in LODOSYN?	LODOSYN excipients list
DailyMed Link:	LODOSYN at DailyMed

Drug patent expirations by year for LODOSYN

Recent Clinical Trials for LODOSYN

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University of Miami	Phase 2
Daniel Claassen	Phase 1
University of Miami	Phase 1

See all LODOSYN clinical trials

US Patents and Regulatory Information for LODOSYN

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Aton	LODOSYN	carbidopa	TABLET;ORAL	017830-001	Approved Prior to Jan 1, 1982	AB	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for LODOSYN

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Aton	LODOSYN	carbidopa	TABLET;ORAL	017830-001	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Aton	LODOSYN	carbidopa	TABLET;ORAL	017830-001	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Aton	LODOSYN	carbidopa	TABLET;ORAL	017830-001	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for LODOSYN

See the table below for patents covering LODOSYN around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Romania	62402		⤷ Sign Up
U.S.S.R.	455530		⤷ Sign Up
Poland	100989		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for LODOSYN

Recent Clinical Trials for LODOSYN

Make Better Decisions: Try a trial or see plans & pricing